PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
09-Dec-2025 Accomplished Communications Leader Ann Hemingway Joins Sam Brown as Managing Director, Account Services Businesswire
09-Dec-2025 Kelonia Therapeutics Presents First-in-Human Data From Phase 1 inMMyCAR Study of KLN-1010 in vivo BCMA CAR-T Therapy at the American Society of Hematology (ASH) 2025 Annual Meeting Businesswire
09-Dec-2025 ICON 2025 global biotech survey solidifies China dominance and highlights opportunities for Western biotechs to stay competitive Businesswire
09-Dec-2025 PepGen Reports Inducement Grant under Nasdaq Listing Rule 5635(c)(4) to Newly Appointed Chief Business and Legal Officer Businesswire
09-Dec-2025 Satellos Receives Clearance by U.S. FDA and Global Regulators to Initiate Pediatric Phase 2 Study of SAT-3247 for Duchenne Muscular Dystrophy Businesswire
09-Dec-2025 RunSafe Security Releases 2025 AI in Embedded Systems Report Offering New Insight Into AI Adoption and Security Gaps Businesswire
09-Dec-2025 SciencePower Collaborates to Advance Research on Postbiotics in Breast Cancer Biology Businesswire
09-Dec-2025 SAGA Diagnostics’ Pathlight™ MRD Further Demonstrates Clinical Validity In TNBC Trials Presented at SABCS Businesswire
09-Dec-2025 Biogen Receives Health Canada Authorization for ZURZUVAE™ (zuranolone), the First and Only Treatment Indicated for Adults with Postpartum Depression in Canada Businesswire
09-Dec-2025 Pfizer Enters into Exclusive Collaboration and License Agreement with YaoPharma Businesswire
09-Dec-2025 Compass Pathways to Host Webinar on Commercial Preparations for Treatment-Resistant Depression (TRD) and Clinical Trial Plans for Post-Traumatic Stress Disorder (PTSD) on January 7, 2026, 10:00am ET Businesswire
09-Dec-2025 Campo Indictment Exposes DEA Rotted From Within - While Medical Cannabis Research and Patients Wait Seven Years ACCESS Newswire
09-Dec-2025 Most Americans With OCD Never Receive Effective Treatment, Landmark Study Finds ACCESS Newswire
09-Dec-2025 OPEN Health Welcomes Diala Habib to Drive a New Era of Human-Centric Engagement Connecting HCPs, Patients, and Purpose OPEN Health
09-Dec-2025 2026 Regulatory Crossfire: New Outlook Survey Reveals Health IT Rules Reshaping U.S. Care Delivery ACCESS Newswire
09-Dec-2025 World’s First Patients Successfully Treated With Novel Scarcell Therapeutics Therapy Using Gum Cells Designed to Relieve Knee Osteoarthritis Businesswire
09-Dec-2025 A glass of red wine this Christmas could be good for you, says expert. It’s ‘The French Paradox’! Sinclair Method UK
09-Dec-2025 Oncoinvent Announces Publication of Phase 1 Study Results for Radspherin® in Ovarian Cancer in Gynecologic Oncology Oncoinvent
09-Dec-2025 Newron announces the US initiation of its ENIGMA-TRS 2 Phase III global clinical study with evenamide as an add-on therapy for patients with treatment-resistant schizophrenia (TRS) Newron
09-Dec-2025 PureTech Announces Successful End-of-Phase 2 Meeting with FDA for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis PureTech